Results of the randomised phase II NCRI arctic (attenuated dose rituximab with chemotherapy in CLL) trial of low dose rituximab in previously untreated CLL

Bibliographic Details
Main Authors:	Munir, T, Cohen, D, Milligan, D, Schuh, A, McParland, L, Chalmers, A, Varghese, A, Rawstron, A, Allsup, D, Marshall, S, Smith, A, Collett, C, Gregory, W, Duncombe, A, Hillmen, P
Format:	Journal article
Published:	2014

Similar Items